Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavlo Gilchuk

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|September 16, 2020
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognitionAllison J Greaney, Tyler N Starr, Pavlo Gilchuk, et al.
Cell Host & Microbe|December 1, 2020
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionAllison J Greaney, Tyler N Starr, Pavlo Gilchuk, et al.
Cell Reports|August 19, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Iscience|December 13, 2021
Standardized two-step testing of antibody activity in COVID-19 convalescent plasmaPavlo Gilchuk, Isaac Thomsen, Sandra Yoder, et al.
Cell|October 22, 2016
Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus InfectionsIuliia Gilchuk, Pavlo Gilchuk, Gopal Sapparapu, et al.
Research Square|February 17, 2021
SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodiesMichael Diamond, Rita Chen, Xuping Xie, et al.
Cell Reports|April 8, 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypesElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Research Square|May 20, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsMichael Diamond, Rita Chen, Emma Winkler, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktailJinhui Dong, Seth Zost, Allison Greaney, et al.
Med (New York, N.Y.)|February 8, 2022
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaquesRonald R Cobb, Joseph Nkolola, Pavlo Gilchuk, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|September 16, 2020
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognitionAllison J Greaney, Tyler N Starr, Pavlo Gilchuk, et al.
Cell Host & Microbe|December 1, 2020
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionAllison J Greaney, Tyler N Starr, Pavlo Gilchuk, et al.
Cell Reports|August 19, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Iscience|December 13, 2021
Standardized two-step testing of antibody activity in COVID-19 convalescent plasmaPavlo Gilchuk, Isaac Thomsen, Sandra Yoder, et al.
Cell|October 22, 2016
Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus InfectionsIuliia Gilchuk, Pavlo Gilchuk, Gopal Sapparapu, et al.
Research Square|February 17, 2021
SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodiesMichael Diamond, Rita Chen, Xuping Xie, et al.
Cell Reports|April 8, 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypesElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Research Square|May 20, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsMichael Diamond, Rita Chen, Emma Winkler, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktailJinhui Dong, Seth Zost, Allison Greaney, et al.
Med (New York, N.Y.)|February 8, 2022
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaquesRonald R Cobb, Joseph Nkolola, Pavlo Gilchuk, et al.
Pageof 8